US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy
Clinical Infectious Diseases · 2024
DOI: 10.1093/cid/ciad659 ↗At a glance
Leitlinie in Clinical Infectious Diseases, 2024. Written by Sonya Krishnan and 1 co-authors. Institution: Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Major MEDLINE topics: Tuberculosis, Latent Tuberculosis. Cited 3 times so far (Crossref); 43 references. The full text is freely available in PubMed Central. Funded by: NIAID NIH HHS, NIH HHS, NIH.
Abstract (original language)
The provision of tuberculosis-preventive therapy (TPT) to vulnerable populations is critical for global control. Shorter-course TPT regimens are highly effective and improve completion rates. Despite incorporation of 1 month of rifapentine and isoniazid into global guidelines, current US TPT guidelines do not include this as a recommended regimen, but should.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Center for Tuberculosis Research, Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
ORCID profiles: Sonya Krishnan, Richard E Chaisson
Funding
- NIAID NIH HHS
- NIH HHS
- NIH
- Tuberculosis Research Advancement Center
- Center for AIDS Research
Cite
APA
Krishnan, S., & Chaisson, R. E. (2024). US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad659
Vancouver
Krishnan S, Chaisson RE. US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciad659
BibTeX
@article{Krishnan2024,
author = {Krishnan, Sonya and Chaisson, Richard E},
title = {US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy},
journal = {Clinical Infectious Diseases},
year = {2024},
doi = {10.1093/cid/ciad659}
}
EUVIMED